What is GenScript?
Founded in 2002 and headquartered in Piscataway, New Jersey, GenScript stands as a global leader in the biotechnology industry, offering comprehensive life sciences services and products. The company operates across four distinct platforms: a leading life-science services and products platform providing one-stop solutions for global research communities; a biologics contract development and manufacturing organization (CDMO) platform; an industrial synthetic products platform; and an integrated global cell therapy platform. This multi-faceted approach positions GenScript as a pivotal player in advancing biological research and therapeutic development.
How much funding has GenScript raised?
GenScript has raised a total of $67.6M across 1 funding round:
Stock Offering
$67.6M
Stock Issuance/Offering (2015): $67.6M, investors not publicly disclosed
What's next for GenScript?
With the recent injection of major strategic investment, GenScript is poised for significant advancements. The substantial capital backing, contributing to its overall $67.6M, suggests a strategic focus on scaling its CDMO capabilities, expanding its industrial synthetic products, and further developing its integrated global cell therapy platform. This financing round is indicative of the company's robust growth trajectory and its commitment to innovation within the competitive biotech landscape. Future developments are likely to center on enhancing its service offerings and solidifying its market leadership.
See full GenScript company page
